Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study is being done to see if the addition of mangosteen juice to standard medical care
will reduce the risk of atrial fibrillation (AF) recurrence following direct current (DC)
cardioversion. The study will also look at the effects the mangosteen juice may have on
biomarkers of inflammation and endothelial cell dysfunction (the tissue lining the arteries
does not function properly).